
27-01-2020 Print
Anglo-Swedish drugmaker AstraZeneca has agreed to sell the commercial rights to Inderal (propranolol),…
To continue reading The Pharma Letter please login, subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space.
AstraZenecaAtnahs PharmaCardio-vascularCompanies, mergers and acquisitionsDealsInderalManagementPharmaceuticalSwedenTenoreticTenorminUKZestoreticZestril



